- ►thecybertramp.com [PDF] JE Bekelman, Y Li, CP Gross - Jama, 2003 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 681 - Related articles - BL Direct - All 9 versions
AM Lincoff, JA Bittl, RA Harrington, F Feit, … - Jama, 2003 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 503 - Related articles - BL Direct - All 8 versions
BT Walsh, SN Seidman, R Sysko, M Gould - Jama, 2002 - Am Med Assoc Context Intense debate persists about the need for placebo-controlled groups in
clinical trials of medications for major depressive disorder (MDD). There is
continuing interest in the development of new medications, but because ... Cited by 399 - Related articles - BL Direct - All 4 versions
- ►woodymatters.com [PDF] EH Turner, AM Matthews, E Linardatos, RA … - New England Journal of Medicine, 2008 - content.nejm.org Results Among 74 FDA-registered studies, 31%, accounting for 3449 study
participants, were not published. Whether and how the studies were published
were associated with the study outcome. A total of 37 studies viewed by the ... Cited by 312 - Related articles - BL Direct - All 25 versions
PAGM De Smet - New England Journal of Medicine, 2002 - content.nejm.org Several countries (eg, Germany, France, Sweden, and Australia) have implemented
strategies for licensing herbal remedies. In Germany, such products can be
registered as medicines on the basis of information in approximately 300 ... Cited by 298 - Related articles - All 6 versions
KE Andersson, R Appell, LD Cardozo, C … - BJU international, 1999 - icsoffice.org Page 1. Committee 10 Pharmacological Treatment of Urinary Incontinence Chairman
KE ANDERSSON (SWEDEN) Members R. APPELL (USA), L. CARDOZO (UK), C. CHAPPLE (UK), ... Cited by 236 - Related articles - BL Direct - All 9 versions
EAM Gale - The Lancet, 2001 - Elsevier Troglitazone, the first in the thiazolidinedione class of oral hypoglycaemic
agents, was launched in the USA in March, 1997. It reached Europe later that
year, only to be withdrawn within weeks on the grounds of liver toxicity. ... Cited by 174 - Related articles - BL Direct - All 5 versions
EJ Emanuel, FG Miller - The New England journal of medicine, 2001 - nejm.highwire.org The first placebo-controlled trial was probably conducted in 1931, when
sanocrysin was compared with distilled water for the treatment of tuberculosis.
1 Ever since then, placebo-controlled trials have been controversial, ... Cited by 164 - Related articles - BL Direct - All 16 versions
- ►annals.org SS Ellenberg, R Temple - Annals of Internal Medicine, 2000 - Am Coll Physicians Placebo controls are commonly used in clinical trials of investigational
treatments because they have important advantages. In recent years, some have
criticized the use of placebo-controlled trials when effective alternative ... Cited by 164 - Related articles - BL Direct - All 7 versions
- ►uwo.ca [PDF] FG Miller, H Brody - Hastings Center Report, 2003 - jstor.org T he prevailing ethical perspective on clinical trials holds that physi-
cian-investigators can discharge their "therapeutic obligation" to patients in
the context of randomized clinical tri- als (RCTs) as long as treatments ... Cited by 137 - Related articles - BL Direct - All 6 versions
